MANHATTAN ASSOCIATES INC (MANH) Fundamental Analysis & Valuation

NASDAQ:MANH • US5627501092

145.13 USD
-5.03 (-3.35%)
Last: Mar 10, 2026, 03:03 PM

This MANH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

MANH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. MANH scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MANH has a correct valuation and a medium growth rate. These ratings could make MANH a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. MANH Profitability Analysis

1.1 Basic Checks

  • MANH had positive earnings in the past year.
  • In the past year MANH had a positive cash flow from operations.
  • In the past 5 years MANH has always been profitable.
  • In the past 5 years MANH always reported a positive cash flow from operatings.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 26.20%, MANH belongs to the top of the industry, outperforming 98.19% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 69.88%, MANH belongs to the top of the industry, outperforming 97.83% of the companies in the same industry.
  • MANH has a better Return On Invested Capital (58.53%) than 98.92% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MANH is significantly above the industry average of 10.89%.
  • The 3 year average ROIC (56.95%) for MANH is below the current ROIC(58.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROIC 58.53%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • With an excellent Profit Margin value of 20.34%, MANH belongs to the best of the industry, outperforming 86.64% of the companies in the same industry.
  • MANH's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 26.15%, MANH belongs to the best of the industry, outperforming 91.34% of the companies in the same industry.
  • MANH's Operating Margin has improved in the last couple of years.
  • MANH has a worse Gross Margin (56.32%) than 64.62% of its industry peers.
  • In the last couple of years the Gross Margin of MANH has remained more or less at the same level.
Industry RankSector Rank
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

9

2. MANH Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
  • MANH has less shares outstanding than it did 1 year ago.
  • MANH has less shares outstanding than it did 5 years ago.
  • MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • MANH has an Altman-Z score of 13.44. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
  • MANH has a better Altman-Z score (13.44) than 94.22% of its industry peers.
  • MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.44
ROIC/WACC5.37
WACC10.91%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.3 Liquidity

  • MANH has a Current Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.28, MANH is doing worse than 61.37% of the companies in the same industry.
  • MANH has a Quick Ratio of 1.28. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
  • MANH's Quick ratio of 1.28 is on the low side compared to the rest of the industry. MANH is outperformed by 60.29% of its industry peers.
  • MANH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.28
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

6

3. MANH Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.19% over the past year.
  • Measured over the past years, MANH shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.57% on average per year.
  • The Revenue has been growing slightly by 3.75% in the past year.
  • The Revenue has been growing by 13.02% on average over the past years. This is quite good.
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%

3.2 Future

  • MANH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.98% yearly.
  • The Revenue is expected to grow by 8.85% on average over the next years. This is quite good.
EPS Next Y4.92%
EPS Next 2Y8.76%
EPS Next 3Y9.79%
EPS Next 5Y18.98%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.05%
Revenue Next 5Y8.85%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

4

4. MANH Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.63, the valuation of MANH can be described as expensive.
  • Based on the Price/Earnings ratio, MANH is valued a bit cheaper than the industry average as 61.37% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.45. MANH is around the same levels.
  • MANH is valuated quite expensively with a Price/Forward Earnings ratio of 27.28.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of MANH is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.65, MANH is valued at the same level.
Industry RankSector Rank
PE 28.63
Fwd PE 27.28
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 68.23% of the companies in the same industry are more expensive than MANH, based on the Enterprise Value to EBITDA ratio.
  • MANH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MANH is cheaper than 69.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.22
EV/EBITDA 29.95
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • MANH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)5.82
PEG (5Y)1.21
EPS Next 2Y8.76%
EPS Next 3Y9.79%

0

5. MANH Dividend Analysis

5.1 Amount

  • No dividends for MANH!.
Industry RankSector Rank
Dividend Yield 0%

MANH Fundamentals: All Metrics, Ratios and Statistics

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (3/10/2026, 3:03:10 PM)

145.13

-5.03 (-3.35%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-27
Earnings (Next)04-20
Inst Owners105.66%
Inst Owner Change-2.41%
Ins Owners1.18%
Ins Owner Change-1.47%
Market Cap8.69B
Revenue(TTM)1.08B
Net Income(TTM)219.95M
Analysts83.16
Price Target217.19 (49.65%)
Short Float %5.12%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.54%
Min EPS beat(2)5.72%
Max EPS beat(2)13.36%
EPS beat(4)4
Avg EPS beat(4)11.67%
Min EPS beat(4)5.72%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)14.56%
EPS beat(12)12
Avg EPS beat(12)18.24%
EPS beat(16)16
Avg EPS beat(16)21.82%
Revenue beat(2)0
Avg Revenue beat(2)-0.34%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.26%
Revenue beat(8)4
Avg Revenue beat(8)0.46%
Revenue beat(12)8
Avg Revenue beat(12)1.99%
Revenue beat(16)12
Avg Revenue beat(16)2.69%
PT rev (1m)-2.09%
PT rev (3m)-5.75%
EPS NQ rev (1m)-1.06%
EPS NQ rev (3m)-9.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.71%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 28.63
Fwd PE 27.28
P/S 8.03
P/FCF 23.22
P/OCF 22.3
P/B 27.6
P/tB 34.4
EV/EBITDA 29.95
EPS(TTM)5.07
EY3.49%
EPS(NY)5.32
Fwd EY3.67%
FCF(TTM)6.25
FCFY4.31%
OCF(TTM)6.51
OCFY4.48%
SpS18.07
BVpS5.26
TBVpS4.22
PEG (NY)5.82
PEG (5Y)1.21
Graham Number24.49
Profitability
Industry RankSector Rank
ROA 26.2%
ROE 69.88%
ROCE 73.73%
ROIC 58.53%
ROICexc 410.13%
ROICexgc N/A
OM 26.15%
PM (TTM) 20.34%
GM 56.32%
FCFM 34.59%
ROA(3y)27.08%
ROA(5y)24.87%
ROE(3y)68.78%
ROE(5y)61.46%
ROIC(3y)56.95%
ROIC(5y)51.03%
ROICexc(3y)364.11%
ROICexc(5y)380.76%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)71.74%
ROCE(5y)64.28%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-0.52%
ROICexc growth 5Y23.6%
OM growth 3Y9.51%
OM growth 5Y6.09%
PM growth 3Y6.54%
PM growth 5Y6.46%
GM growth 3Y1.86%
GM growth 5Y0.86%
F-Score7
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 244.69%
Cap/Sales 1.43%
Interest Coverage 250
Cash Conversion 134.74%
Profit Quality 170.05%
Current Ratio 1.28
Quick Ratio 1.28
Altman-Z 13.44
F-Score7
WACC10.91%
ROIC/WACC5.37
Cap/Depr(3y)154.87%
Cap/Depr(5y)122.75%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.85%
Profit Quality(3y)145.98%
Profit Quality(5y)147.21%
High Growth Momentum
Growth
EPS 1Y (TTM)7.19%
EPS 3Y22.47%
EPS 5Y23.57%
EPS Q2Q%3.42%
EPS Next Y4.92%
EPS Next 2Y8.76%
EPS Next 3Y9.79%
EPS Next 5Y18.98%
Revenue 1Y (TTM)3.75%
Revenue growth 3Y12.13%
Revenue growth 5Y13.02%
Sales Q2Q%5.7%
Revenue Next Year6.47%
Revenue Next 2Y7.63%
Revenue Next 3Y8.05%
Revenue Next 5Y8.85%
EBIT growth 1Y8.08%
EBIT growth 3Y22.8%
EBIT growth 5Y19.9%
EBIT Next Year8.14%
EBIT Next 3Y9.69%
EBIT Next 5Y13.03%
FCF growth 1Y30.62%
FCF growth 3Y29.3%
FCF growth 5Y22.03%
OCF growth 1Y32.02%
OCF growth 3Y29.44%
OCF growth 5Y22.55%

MANHATTAN ASSOCIATES INC / MANH FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status for MANH stock?

ChartMill assigns a valuation rating of 4 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Fairly Valued.


How profitable is MANHATTAN ASSOCIATES INC (MANH) stock?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


How financially healthy is MANHATTAN ASSOCIATES INC?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.


What is the expected EPS growth for MANHATTAN ASSOCIATES INC (MANH) stock?

The Earnings per Share (EPS) of MANHATTAN ASSOCIATES INC (MANH) is expected to grow by 4.92% in the next year.